WELLCOME
Trademark Status DEAD
Expiration 19.04.2014

Grant

Russian Federation

2024-06-07

1.409.072™

RU

50809

15.10.1974

Application

Russian Federation

2024-06-07

1.409.072™

RU APP

68373

19.04.1974

Classes

Текст Текст Текст View in office

Owner

ДЗЕ ВЕЛКОМ ФАУНДЕЙШН ЛИМИТЕД (GB)

Classes

03

NICE Classification

  • фармацевтические препараты;
  • медицинские;
  • биологические;
  • ветеринарные средства;
  • препараты для уничтожения насекомых у скота;
  • инсектициды;
  • дезинфицирующие средства;
  • дезодоранты;
  • медицинские туалетные и косметические препараты и шампуни;
05

NICE Classification

  • фармацевтические препараты;
  • медицинские;
  • биологические;
  • ветеринарные средства;
  • препараты для уничтожения насекомых у скота;
  • инсектициды;
  • дезинфицирующие средства;
  • дезодоранты;
  • медицинские туалетные и косметические препараты и шампуни;

Domain names similar "WELLCOME"

News around "WELLCOME" trademark

News sentiment analysis powered by sentiment-insight.com
2023-10-13
neutral
Queensland researchers have begun a trial to use technology to keep older people safe as temperatures warm. The trial uses an an app to alert older people when they are at risk of rising temperatures in their homes. The project is funded through a $2.35 million grant from global charitable foundation Wellcome.
2023-06-30
positive
Bill and Melinda Gates Foundation and Wellcome will put about $550 million into trials. The shot, called M72, has been on hold since 2019, when GSK abandoned it. M72 would be the first new vaccine in a century to target a disease that killed 1.6 million in 2021.
2023-06-28
positive
Wellcome and the Bill & Melinda Gates Foundation will invest around $550 million in total for the Phase III trials of the M72 vaccine. The trial is set to take 4-6 years, among 26,000 people at more than 50 sites across Africa and Southeast Asia. The vaccine will be tested to see how well it prevents latent TB from becoming active TB.
2023-06-28
positive
Wellcome and the Bill & Melinda Gates Foundation will invest around $550 million in total for the Phase III trials of the M72 vaccine. TB, a bacterial disease that mostly affects the lungs, is preventable and treatable. The existing TB vaccine - Bacille Calmette-Guérin (BCG) – was first given in 1921.
2023-06-28
positive
Wellcome and the Bill & Melinda Gates Foundation will invest around $550 million in total for the Phase III trials of the M72 vaccine. TB, a bacterial disease that mostly affects the lungs, is preventable and treatable. 10 million people still catch it annually, and 1.6 million people died from TB in 2021.
2023-06-28
positive
Wellcome charity and Microsoft founder Bill Gates join forces to help co-fund final clinical trials of the most promising TB vaccine candidate in a century. Immunity from the current ECB childhood jab - the most widely used vaccine in the world - wanes before the teenage years.
2023-05-15
positive
A $2.3 million grant from U.K.-based charity Wellcome is funding a data skilling program run by data.org. The India Data Capacity Accelerator envisions one million Indians trained in using data to solve climate and health-related challenges.
2023-05-15
positive
A $2.3 million grant from U.K.-based charity Wellcome is funding a data skilling program run by data.org to launch the India Data Capacity Accelerator. The program envisions one million Indians trained in using data to solve climate and health-related challenges.
2023-02-20
negative
Prof Jeremy Farrar, director of Wellcome, says healthcare workers are 'absolutely shattered' Comments come as thousands of ambulance workers go on strike on Monday. The union is increasing the day rate for those on the picket line from £50 to £80.
2023-02-16
positive
Cannabidiol (CBD) is a chemical found in marijuana, but it does not contain tetrahydrocannabinol (THC), the ingredient in marijuana which produces a feeling of being high. Oxford University’s department of psychiatry has been awarded £16.5m by charitable foundation Wellcome to launch a clinical trial.
2023-02-16
positive
Cannabidiol (CBD) is one of the chemicals found in marijuana. It does not contain tetrahydrocannabinol (THC), the ingredient in marijuana which produces a feeling of being high. At the moment, CBD is only prescribed on the NHS for a few conditions. University of Oxford’s Department of Psychiatry has been awarded £16.5 million by charitable foundation Wellcome to launch a global clinical trial.
2023-02-16
positive
The international study will involve 35 centres, mainly in Europe and North America. It will be coordinated by the University of Oxford’s department of psychiatry, which has been awarded £16.5m by the charitable foundation Wellcome.
2023-02-03
positive
Wellcome is supporting global research to address these urgent health threats. Researchers will develop digital tools to model the relationship between climate change and infectious disease. £22.7 million funding will allow these projects to analyse where and when deadly disease outbreaks are likely to occur.
2023-02-03
positive
Wellcome is supporting global research to address these urgent health threats. The £22.7 million funding will allow these projects to analyse where and when deadly disease outbreaks are likely to occur. It will also allow them to prepare healthcare systems.
2023-02-03
positive
Wellcome is supporting global research to address these urgent health threats. The £22.7 million funding will allow these projects to analyse where and when deadly disease outbreaks are likely to occur.

Are you an IP company?

Contact us to learn how to improve your business by cutting your costs, and engaging new customers

Trademark catalog